Publications by authors named "Daniel Neddermann"

Claim this Profile
C
Co-medication and interference testing in bioanalysis: a European Bioanalysis Forum recommendation.
Marcel de Zwart, Berthold Lausecker, Susanne Globig, Daniel Neddermann, Bruno Le Bras

Bioanalysis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice.
Nicolau Beckmann, Arno Doelemeyer, Stefan Zurbruegg, Karine Bigot, Diethilde Theil, Daniel Neddermann

Neurobiol Aging· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of epigenetic mechanisms in the development of chronic complications of diabetes.
Malgorzata Wegner, Daniel Neddermann, Maria Piorunska-Stolzmann, Pawel P Jagodzinski

Diabetes Res Clin Pract· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling.
Manfred Bodenlenz, Christian Höfferer, Christoph Magnes, Roland Schaller-Ammann, Lukas Schaupp, Daniel Neddermann

Eur J Pharm Biopharm· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects.
John M Kovarik, Alan Slade, Gilles-Jacques Riviere, Daniel Neddermann, Steve Maton

Br J Clin Pharmacol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mechanistic study to assess whether isoproterenol can reverse the negative chronotropic effect of fingolimod.
John M Kovarik, Gilles-Jacques Riviere, Daniel Neddermann, Steve Maton, Thomas L Hunt

J Clin Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects.
John M Kovarik, Stefan Hartmann, Michael Bartlett, Gilles-Jacques Riviere, Daniel Neddermann

Biopharm Drug Dispos· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis